Clinical trial evidence shows that ACI can improve the symptoms of articular cartilage defects of the knee. There is evidence that it is likely to be more successful in people who haven’t had any previous knee repair surgery, and in people who have very little osteoarthritic damage in the knee. But, it is unclear how well ACI works in the long term compared with microfracture, the most commonly used alternative treatment.
We are delighted to invite you to join our ICRS Social Media Channels. Follow us today and stay always up to date on the latest news in our field:Any problems viewing this message? Click here to view in your browser
Save up to 250 Euros • First Come – First Serve Policy – Limited to 48 vacancies for the Wet-Lab • Reduced Student / Resident Fees (available until October 31, 2017)
It is an enormous pleasure to welcome over 150 participants from 31 countries and from all 4 corners of the world. We do have confirmed participants from Austria, Bangladesh, Belgium, Brazil, Canada, Chile, Croatia, Denmark, Ecuador, Estonia, France, Germany, Greece, India, Ireland, Italy, South Korea, Malaysia, Mexico, Netherlands, Oman, Poland, Qatar, Russian Federation, Slovenia, Spain, Switzerland, Turkey, UAE, United Kingdom & United States of America – a truly international event!
An exciting position has become available for a postdoctoral fellow to become a member of our highly motivated Team at the Center or Regenerative Medcine at the Danube University Krems.
Vericel (Nasdaq: VCEL), a specialty biologics company with three approved cellular therapy products on the market might still be underappreciated by investors after its recent run?
OR AKIVA, Israel and PRINCETON, New Jersey, August 28, 2017 /PRNewswire/ — Regentis Biomaterials Ltd., a privately held company developing proprietary hydrogels for tissue regeneration, announced today it has received European CE mark approval for its GelrinC® biodegradable implant.
Review of “Allogeneic MSCs and recycled autologous Chondrons mixed in a one-stage cartilage cell transplantation: A first-in-man trial in 35 patients” from STEM CELLS by Stuart P. Atkinson
TELTOW, BERLIN, GERMANY / ACCESSWIRE / July 12, 2017 / Today, CO.DON AG received the Commission’s implementing decision of 10.07.2017 on the granting of marketing authorization for the human pharmaceutical product,
The recently appointed ICRS Patient Registry Consultant Ms Ward Tammy is now available to assist interested Surgeons & Hospitals in using the ICRS cartilage patient registry.
The Editorial board of the ICRS journal ‘Cartilage’ is interested in publishing a Special Issue on one particular cartilage, The Intervertebral Disc. If anyone has any research in this area we would welcome your submissions of manuscripts for consideration.
The ICRS Journal CARTILAGE is extremely proud to announce its ranking of 26 out of 76 journals in orthopaedics, with an Impact Factor of 2.000 (Source: 2016 Journal Citation Reports®, Clarivate Analytics, 2017).
